Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28


A 3-Year-Old Girl With a Mediastinal Mass.

Wentink M, Peeters D, van der Burg M, Vermont C, Duijts L, Driessen GJ.

Chest. 2019 Jan;155(1):e13-e16. doi: 10.1016/j.chest.2018.07.042.


Pharmacokinetics, Short-term Safety and Efficacy of the Approved Once-daily Darunavir/Ritonavir Dosing Regimen in HIV-infected Children.

Bastiaans DET, Geelen SPM, Visser EG, van der Flier M, Vermont CL, Colbers APH, Roukens M, Burger DM, van Rossum AMC; Dutch Paediatric HIV Study Group.

Pediatr Infect Dis J. 2018 Oct;37(10):1008-1010. doi: 10.1097/INF.0000000000001964.


Upsurge of Enterovirus D68, the Netherlands, 2016.

Knoester M, Schölvinck EH, Poelman R, Smit S, Vermont CL, Niesters HG, Van Leer-Buter CC.

Emerg Infect Dis. 2017 Jan;23(1):140-143. doi: 10.3201/eid2301.161313. Epub 2017 Jan 15.


De Novo Trisomy 1q10q23.3 Mosaicism Causes Microcephaly, Severe Developmental Delay, and Facial Dysmorphic Features but No Cardiac Anomalies.

Lo-A-Njoe S, van der Veken LT, Vermont C, Rafael-Croes L, Keizer V, Hochstenbach R, Knoers N, van Haelst MM.

Case Rep Genet. 2016;2016:2861653. doi: 10.1155/2016/2861653. Epub 2016 Jan 31.


The effect of cidofovir on adenovirus plasma DNA levels in stem cell transplantation recipients without T cell reconstitution.

Lugthart G, Oomen MA, Jol-van der Zijde CM, Ball LM, Bresters D, Kollen WJ, Smiers FJ, Vermont CL, Bredius RG, Schilham MW, van Tol MJ, Lankester AC.

Biol Blood Marrow Transplant. 2015 Feb;21(2):293-9. doi: 10.1016/j.bbmt.2014.10.012. Epub 2014 Oct 16.


The diagnostic value of interleukin-8 for the detection of bacteremia in pediatric hematopoietic stem cell recipients with febrile neutropenia.

Miedema KG, Vermont CL, Ball LM, de Bont ES, Kamps WA, van Tol MJ, Jol-van der Zijde CM, Tissing WJ.

Transplantation. 2014 Oct 27;98(8):e80-1. doi: 10.1097/TP.0000000000000434. No abstract available.


Varicella zoster reactivation after hematopoietic stem cell transplant in children is strongly correlated with leukemia treatment and suppression of host T-lymphocyte immunity.

Vermont CL, Jol-van der Zijde EC, Hissink Muller P, Ball LM, Bredius RG, Vossen AC, Lankester AC.

Transpl Infect Dis. 2014 Apr;16(2):188-94. doi: 10.1111/tid.12180. Epub 2014 Jan 20.


Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study.

Güngör T, Teira P, Slatter M, Stussi G, Stepensky P, Moshous D, Vermont C, Ahmad I, Shaw PJ, Telles da Cunha JM, Schlegel PG, Hough R, Fasth A, Kentouche K, Gruhn B, Fernandes JF, Lachance S, Bredius R, Resnick IB, Belohradsky BH, Gennery A, Fischer A, Gaspar HB, Schanz U, Seger R, Rentsch K, Veys P, Haddad E, Albert MH, Hassan M; Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation.

Lancet. 2014 Feb 1;383(9915):436-48. doi: 10.1016/S0140-6736(13)62069-3. Epub 2013 Oct 23.


Targeted next-generation sequencing: a novel diagnostic tool for primary immunodeficiencies.

Nijman IJ, van Montfrans JM, Hoogstraat M, Boes ML, van de Corput L, Renner ED, van Zon P, van Lieshout S, Elferink MG, van der Burg M, Vermont CL, van der Zwaag B, Janson E, Cuppen E, Ploos van Amstel JK, van Gijn ME.

J Allergy Clin Immunol. 2014 Feb;133(2):529-34. doi: 10.1016/j.jaci.2013.08.032. Epub 2013 Oct 15. Erratum in: J Allergy Clin Immunol. 2014 Apr;133(4):1232.


Aberrant humoral immune reactivity in DOCK8 deficiency with follicular hyperplasia and nodal plasmacytosis.

aan de Kerk DJ, van Leeuwen EM, Jansen MH, van den Berg JM, Alders M, Vermont CL, van Lier RA, Pals ST, Kuijpers TW.

Clin Immunol. 2013 Oct;149(1):25-31. doi: 10.1016/j.clim.2013.06.002. Epub 2013 Jun 19.


Persistence and antiviral resistance of varicella zoster virus in hematological patients.

van der Beek MT, Vermont CL, Bredius RG, Marijt EW, van der Blij-de Brouwer CS, Kroes AC, Claas EC, Vossen AC.

Clin Infect Dis. 2013 Feb;56(3):335-43. doi: 10.1093/cid/cis879. Epub 2012 Oct 16.


Deletion of the 3q26 region including the EVI1 and MDS1 genes in a neonate with congenital thrombocytopenia and subsequent aplastic anaemia.

Nielsen M, Vermont CL, Aten E, Ruivenkamp CA, van Herrewegen F, Santen GW, Breuning MH.

J Med Genet. 2012 Sep;49(9):598-600. doi: 10.1136/jmedgenet-2012-100990.


Household transmission of haemolytic uraemic syndrome associated with Escherichia coli O104:H4 in the Netherlands, May 2011.

Kuijper EJ, Soonawala D, Vermont C, van Dissel JT.

Euro Surveill. 2011 Jun 23;16(25). pii: 19897.


Polymorphisms in PARP, IL1B, IL4, IL10, C1INH, DEFB1, and DEFA4 in meningococcal disease in three populations.

Emonts M, Vermont CL, Houwing-Duistermaat JJ, Haralambous E, Gaast-de Jongh CE, Hazelzet JA, Faust SN, Betts H, Hermans PW, Levin M, de Groot R; St. Mary's-Imperial College and Erasmus MC-Sophia Children's Hospitals Meningococcal Research Groups.

Shock. 2010 Jul;34(1):17-22. doi: 10.1097/SHK.0b013e3181ce2c7d.


CC and CXC chemokine levels in children with meningococcal sepsis accurately predict mortality and disease severity.

Vermont CL, Hazelzet JA, de Kleijn ED, van den Dobbelsteen GP, de Groot R.

Crit Care. 2006 Feb;10(1):R33.


Serum lipids and disease severity in children with severe meningococcal sepsis.

Vermont CL, den Brinker M, Kâkeci N, de Kleijn ED, de Rijke YB, Joosten KF, de Groot R, Hazelzet JA.

Crit Care Med. 2005 Jul;33(7):1610-5.


Porin A-specific antibody avidity in patients who are convalescing from meningococcal B disease.

Vermont CL, van Dijken HH, de Groot R, van den Dobbelsteen GP.

Pediatr Res. 2005 Jul;58(1):149-52. Epub 2005 Mar 17.


PorA-specific differences in antibody avidity after vaccination with a hexavalent Men B outer membrane vesicle vaccine in toddlers and school children.

Vermont CL, Van Dijken HH, De Groot R, Van Alphen L, Van Den Dobbelsteen GP.

Vaccine. 2004 Aug 13;22(23-24):3008-13.


Meningococcal serogroup B infections: a search for a broadly protective vaccine.

Vermont CL, van den Dobbelsteen GP.

Expert Rev Vaccines. 2003 Oct;2(5):673-81. Review.


Antibody specificities and effect of meningococcal carriage in icelandic teenagers receiving the Norwegian serogroup B outer membrane vesicle vaccine.

Wedege E, Kuipers B, Bolstad K, van Dijken H, Frøholm LO, Vermont C, Caugant DA, van den Dobbelsteen G.

Infect Immun. 2003 Jul;71(7):3775-81.


Recent developments in vaccines to prevent meningococcal serogroup B infections.

Vermont CL, van den Dobbelsteen GP, de Groot R.

Curr Opin Mol Ther. 2003 Feb;5(1):33-8. Review.


Cross-reactivity of antibodies against PorA after vaccination with a meningococcal B outer membrane vesicle vaccine.

Vermont CL, van Dijken HH, Kuipers AJ, van Limpt CJ, Keijzers WC, van der Ende A, de Groot R, van Alphen L, van den Dobbelsteen GP.

Infect Immun. 2003 Apr;71(4):1650-5.


Neisseria meningitidis serogroup B: laboratory correlates of protection.

Vermont C, van den Dobbelsteen G.

FEMS Immunol Med Microbiol. 2002 Oct 11;34(2):89-96. Review.


Bench-to-bedside review: genetic influences on meningococcal disease.

Vermont CL, de Groot R, Hazelzet JA.

Crit Care. 2002 Feb;6(1):60-5. Epub 2001 Nov 26. Review.


Antibody avidity and immunoglobulin G isotype distribution following immunization with a monovalent meningococcal B outer membrane vesicle vaccine.

Vermont CL, van Dijken HH, van Limpt CJ, de Groot R, van Alphen L, van Den Dobbelsteen GP.

Infect Immun. 2002 Feb;70(2):584-90.


Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccine.

de Kleijn E, van Eijndhoven L, Vermont C, Kuipers B, van Dijken H, Rümke H, de Groot R, van Alphen L, van den Dobbelsteen G.

Vaccine. 2001 Nov 12;20(3-4):352-8.


Radiation dose selection in Hodgkin's disease patients with large mediastinal adenopathy treated with combined modality therapy.

Elconin JH, Roberts KB, Rizzieri DA, Vermont C, Clough RW, Kim C, Dodge RK, Prosnitz LR.

Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):1097-105.


Persistence of clones of coagulase-negative staphylococci among premature neonates in neonatal intensive care units: two-center study of bacterial genotyping and patient risk factors.

Vermont CL, Hartwig NG, Fleer A, de Man P, Verbrugh H, van den Anker J, de Groot R, van Belkum A.

J Clin Microbiol. 1998 Sep;36(9):2485-90.

Supplemental Content

Loading ...
Support Center